0
Your cart

Your cart is empty

Books > Science & Mathematics > Biology, life sciences > Biochemistry

Buy Now

Orphan Drugs and Rare Diseases (Hardcover) Loot Price: R6,111
Discovery Miles 61 110
Orphan Drugs and Rare Diseases (Hardcover): David C. Pryde, Michael Palmer

Orphan Drugs and Rare Diseases (Hardcover)

David C. Pryde, Michael Palmer

Series: Drug Discovery, Volume 38

 (sign in to rate)
Loot Price R6,111 Discovery Miles 61 110 | Repayment Terms: R573 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

Orphan drugs are designated drug substances that are intended to treat rare or 'orphan' diseases. More than 7000 rare diseases are known that collectively affect some 6-7% of the developed world's population; however, individually, any single, rare disease may only affect a handful of people making them commercially unattractive for the biopharmaceutical industry to target. Ground breaking legislation, starting with the Orphan Drug Act that was passed in the US in 1983 to provide financial incentives for companies to develop orphan drugs, has sparked ever increasing interest from biopharmaceutical companies to tackle rare diseases. These developments have made rare diseases, and the orphan drugs that treat them, sufficiently attractive to pharmaceutical development and many pharmaceutical companies now have research units dedicated to this area of research. It is therefore timely to review the area of orphan drugs and some of the basic science, drug discovery and regulatory factors that underpin this important, and growing, area of biomedical research. Written by a combination of academic and industry experts working in the field, this text brings together expert authors in the regulatory, drug development, genetics, biochemistry, patient advocacy group, medicinal chemistry and commercial domains to create a unique and timely reference for all biomedical researchers interested in finding out more about orphan drugs and the rare diseases they treat. Providing an up-to-date monograph, this book covers the basic science, drug discovery and regulatory elements behind orphan drugs and will appeal to medicinal and pharmaceutical chemists, biochemists and anyone working within the fields of rare disease research and drug development or pharmaceuticals in industry or academia.

General

Imprint: Royal Society of Chemistry
Country of origin: United Kingdom
Series: Drug Discovery, Volume 38
Release date: August 2014
First published: 2014
Editors: David C. Pryde • Michael Palmer
Dimensions: 234 x 156 x 33mm (L x W x T)
Format: Hardcover - Unsewn / adhesive bound
Pages: 486
ISBN-13: 978-1-84973-806-4
Categories: Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Science & Mathematics > Biology, life sciences > Biochemistry > General
LSN: 1-84973-806-8
Barcode: 9781849738064

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners